nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzonatate—Nonoxynol-9—PTGS2—breast cancer	0.028	1	CrCbGaD
Benzonatate—SCN5A—Interaction between L1 and Ankyrins—NRCAM—breast cancer	0.00999	0.0801	CbGpPWpGaD
Benzonatate—SCN5A—Interaction between L1 and Ankyrins—SCN10A—breast cancer	0.0089	0.0714	CbGpPWpGaD
Benzonatate—Hypersensitivity—Fluoxymesterone—breast cancer	0.00778	0.00919	CcSEcCtD
Benzonatate—Hypoaesthesia—Letrozole—breast cancer	0.00746	0.0088	CcSEcCtD
Benzonatate—Hypoaesthesia—Raloxifene—breast cancer	0.00708	0.00835	CcSEcCtD
Benzonatate—Sensory loss—Paclitaxel—breast cancer	0.00678	0.00801	CcSEcCtD
Benzonatate—Headache—Fluoxymesterone—breast cancer	0.00662	0.00781	CcSEcCtD
Benzonatate—Constipation—Lapatinib—breast cancer	0.00641	0.00757	CcSEcCtD
Benzonatate—Nausea—Fluoxymesterone—breast cancer	0.00628	0.00741	CcSEcCtD
Benzonatate—Bronchospasm—Melphalan—breast cancer	0.00617	0.00728	CcSEcCtD
Benzonatate—Abdominal discomfort—Tamoxifen—breast cancer	0.00614	0.00725	CcSEcCtD
Benzonatate—Confusional state—Exemestane—breast cancer	0.00604	0.00713	CcSEcCtD
Benzonatate—Constipation—Fulvestrant—breast cancer	0.0059	0.00696	CcSEcCtD
Benzonatate—Eruption—Methotrexate—breast cancer	0.00584	0.00689	CcSEcCtD
Benzonatate—Constipation—Toremifene—breast cancer	0.00582	0.00687	CcSEcCtD
Benzonatate—Shock—Ixabepilone—breast cancer	0.00556	0.00657	CcSEcCtD
Benzonatate—Hypersensitivity—Lapatinib—breast cancer	0.00553	0.00652	CcSEcCtD
Benzonatate—Eruption—Epirubicin—breast cancer	0.00546	0.00645	CcSEcCtD
Benzonatate—Bronchospasm—Vinorelbine—breast cancer	0.00539	0.00636	CcSEcCtD
Benzonatate—Confusional state—Anastrozole—breast cancer	0.00537	0.00634	CcSEcCtD
Benzonatate—Convulsion—Idarubicin—breast cancer	0.00536	0.00633	CcSEcCtD
Benzonatate—Pruritus—Lapatinib—breast cancer	0.00531	0.00626	CcSEcCtD
Benzonatate—Hypoaesthesia—Vinblastine—breast cancer	0.00525	0.0062	CcSEcCtD
Benzonatate—Constipation—Exemestane—breast cancer	0.00512	0.00605	CcSEcCtD
Benzonatate—Hypoaesthesia—Tamoxifen—breast cancer	0.0051	0.00602	CcSEcCtD
Benzonatate—Hypersensitivity—Fulvestrant—breast cancer	0.00508	0.006	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—RANBP9—breast cancer	0.00506	0.0406	CbGpPWpGaD
Benzonatate—Eruption—Doxorubicin—breast cancer	0.00505	0.00596	CcSEcCtD
Benzonatate—Shock—Raloxifene—breast cancer	0.00497	0.00587	CcSEcCtD
Benzonatate—Shock—Idarubicin—breast cancer	0.00497	0.00587	CcSEcCtD
Benzonatate—Feeling abnormal—Exemestane—breast cancer	0.00494	0.00583	CcSEcCtD
Benzonatate—Pruritus—Fulvestrant—breast cancer	0.00488	0.00576	CcSEcCtD
Benzonatate—Constipation—Ixabepilone—breast cancer	0.00483	0.00571	CcSEcCtD
Benzonatate—Pruritus—Toremifene—breast cancer	0.00482	0.00569	CcSEcCtD
Benzonatate—Rash—Lapatinib—breast cancer	0.00473	0.00558	CcSEcCtD
Benzonatate—Headache—Lapatinib—breast cancer	0.0047	0.00555	CcSEcCtD
Benzonatate—Tremor—Chlorambucil—breast cancer	0.0047	0.00554	CcSEcCtD
Benzonatate—Nasal congestion—Paclitaxel—breast cancer	0.00468	0.00553	CcSEcCtD
Benzonatate—Depressed level of consciousness—Capecitabine—breast cancer	0.00466	0.0055	CcSEcCtD
Benzonatate—Agitation—Chlorambucil—breast cancer	0.00461	0.00544	CcSEcCtD
Benzonatate—Dizziness—Fulvestrant—breast cancer	0.00456	0.00538	CcSEcCtD
Benzonatate—Constipation—Anastrozole—breast cancer	0.00455	0.00537	CcSEcCtD
Benzonatate—Constipation—Letrozole—breast cancer	0.00455	0.00537	CcSEcCtD
Benzonatate—Dizziness—Toremifene—breast cancer	0.0045	0.00531	CcSEcCtD
Benzonatate—Nausea—Lapatinib—breast cancer	0.00446	0.00526	CcSEcCtD
Benzonatate—Hypersensitivity—Exemestane—breast cancer	0.00441	0.00521	CcSEcCtD
Benzonatate—Feeling abnormal—Letrozole—breast cancer	0.00439	0.00518	CcSEcCtD
Benzonatate—Feeling abnormal—Anastrozole—breast cancer	0.00439	0.00518	CcSEcCtD
Benzonatate—Hypoaesthesia—Vinorelbine—breast cancer	0.00436	0.00515	CcSEcCtD
Benzonatate—Rash—Fulvestrant—breast cancer	0.00435	0.00513	CcSEcCtD
Benzonatate—Convulsion—Chlorambucil—breast cancer	0.00434	0.00513	CcSEcCtD
Benzonatate—Bronchospasm—Gemcitabine—breast cancer	0.00433	0.00511	CcSEcCtD
Benzonatate—Headache—Fulvestrant—breast cancer	0.00432	0.0051	CcSEcCtD
Benzonatate—Rash—Toremifene—breast cancer	0.00429	0.00507	CcSEcCtD
Benzonatate—Headache—Toremifene—breast cancer	0.00427	0.00503	CcSEcCtD
Benzonatate—Pruritus—Exemestane—breast cancer	0.00424	0.005	CcSEcCtD
Benzonatate—Hypersensitivity—Ixabepilone—breast cancer	0.00417	0.00492	CcSEcCtD
Benzonatate—Confusional state—Chlorambucil—breast cancer	0.00413	0.00487	CcSEcCtD
Benzonatate—Nausea—Fulvestrant—breast cancer	0.0041	0.00484	CcSEcCtD
Benzonatate—Nausea—Toremifene—breast cancer	0.00404	0.00477	CcSEcCtD
Benzonatate—Pruritus—Ixabepilone—breast cancer	0.004	0.00472	CcSEcCtD
Benzonatate—Convulsion—Vinblastine—breast cancer	0.00398	0.0047	CcSEcCtD
Benzonatate—Dizziness—Exemestane—breast cancer	0.00396	0.00468	CcSEcCtD
Benzonatate—Hypersensitivity—Anastrozole—breast cancer	0.00392	0.00463	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—NRCAM—breast cancer	0.00383	0.0307	CbGpPWpGaD
Benzonatate—Convulsion—Melphalan—breast cancer	0.00379	0.00447	CcSEcCtD
Benzonatate—Rash—Exemestane—breast cancer	0.00378	0.00446	CcSEcCtD
Benzonatate—Pruritus—Letrozole—breast cancer	0.00377	0.00445	CcSEcCtD
Benzonatate—Pruritus—Anastrozole—breast cancer	0.00377	0.00445	CcSEcCtD
Benzonatate—Headache—Exemestane—breast cancer	0.00375	0.00443	CcSEcCtD
Benzonatate—Dizziness—Ixabepilone—breast cancer	0.00374	0.00441	CcSEcCtD
Benzonatate—Hypersensitivity—Idarubicin—breast cancer	0.00372	0.00439	CcSEcCtD
Benzonatate—Convulsion—Goserelin—breast cancer	0.00369	0.00436	CcSEcCtD
Benzonatate—Rash—Ixabepilone—breast cancer	0.00356	0.00421	CcSEcCtD
Benzonatate—Nausea—Exemestane—breast cancer	0.00356	0.0042	CcSEcCtD
Benzonatate—Headache—Ixabepilone—breast cancer	0.00354	0.00418	CcSEcCtD
Benzonatate—Dizziness—Letrozole—breast cancer	0.00352	0.00416	CcSEcCtD
Benzonatate—Dizziness—Anastrozole—breast cancer	0.00352	0.00416	CcSEcCtD
Benzonatate—Confusional state—Goserelin—breast cancer	0.00351	0.00414	CcSEcCtD
Benzonatate—Depressed level of consciousness—Methotrexate—breast cancer	0.00347	0.00409	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—DKK1—breast cancer	0.00346	0.0277	CbGpPWpGaD
Benzonatate—Hypoaesthesia—Fluorouracil—breast cancer	0.00345	0.00407	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—DLX2—breast cancer	0.00343	0.0275	CbGpPWpGaD
Benzonatate—Shock—Goserelin—breast cancer	0.00342	0.00404	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—SCN10A—breast cancer	0.00342	0.0274	CbGpPWpGaD
Benzonatate—Feeling abnormal—Chlorambucil—breast cancer	0.00337	0.00398	CcSEcCtD
Benzonatate—Nausea—Ixabepilone—breast cancer	0.00336	0.00396	CcSEcCtD
Benzonatate—Rash—Letrozole—breast cancer	0.00336	0.00396	CcSEcCtD
Benzonatate—Rash—Anastrozole—breast cancer	0.00336	0.00396	CcSEcCtD
Benzonatate—Agitation—Thiotepa—breast cancer	0.00335	0.00396	CcSEcCtD
Benzonatate—Dizziness—Raloxifene—breast cancer	0.00334	0.00394	CcSEcCtD
Benzonatate—Headache—Anastrozole—breast cancer	0.00334	0.00394	CcSEcCtD
Benzonatate—Headache—Letrozole—breast cancer	0.00334	0.00394	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—BMP4—breast cancer	0.00324	0.026	CbGpPWpGaD
Benzonatate—Constipation—Vinblastine—breast cancer	0.00321	0.00379	CcSEcCtD
Benzonatate—Rash—Raloxifene—breast cancer	0.00319	0.00376	CcSEcCtD
Benzonatate—Rash—Idarubicin—breast cancer	0.00319	0.00376	CcSEcCtD
Benzonatate—Headache—Raloxifene—breast cancer	0.00317	0.00374	CcSEcCtD
Benzonatate—Headache—Idarubicin—breast cancer	0.00317	0.00374	CcSEcCtD
Benzonatate—Nausea—Anastrozole—breast cancer	0.00316	0.00373	CcSEcCtD
Benzonatate—Nausea—Letrozole—breast cancer	0.00316	0.00373	CcSEcCtD
Benzonatate—Convulsion—Thiotepa—breast cancer	0.00316	0.00373	CcSEcCtD
Benzonatate—Constipation—Tamoxifen—breast cancer	0.00312	0.00368	CcSEcCtD
Benzonatate—Feeling abnormal—Vinblastine—breast cancer	0.00309	0.00365	CcSEcCtD
Benzonatate—Bronchospasm—Docetaxel—breast cancer	0.00307	0.00363	CcSEcCtD
Benzonatate—Hypersensitivity—Chlorambucil—breast cancer	0.00302	0.00356	CcSEcCtD
Benzonatate—Nausea—Raloxifene—breast cancer	0.003	0.00354	CcSEcCtD
Benzonatate—Nausea—Idarubicin—breast cancer	0.003	0.00354	CcSEcCtD
Benzonatate—Confusional state—Thiotepa—breast cancer	0.003	0.00354	CcSEcCtD
Benzonatate—Constipation—Goserelin—breast cancer	0.00298	0.00351	CcSEcCtD
Benzonatate—Bronchospasm—Capecitabine—breast cancer	0.00298	0.00351	CcSEcCtD
Benzonatate—Hypoaesthesia—Paclitaxel—breast cancer	0.00294	0.00347	CcSEcCtD
Benzonatate—Abdominal discomfort—Capecitabine—breast cancer	0.0029	0.00342	CcSEcCtD
Benzonatate—Pruritus—Chlorambucil—breast cancer	0.0029	0.00342	CcSEcCtD
Benzonatate—Feeling abnormal—Goserelin—breast cancer	0.00287	0.00338	CcSEcCtD
Benzonatate—Hypersensitivity—Vinblastine—breast cancer	0.00276	0.00326	CcSEcCtD
Benzonatate—Convulsion—Mitoxantrone—breast cancer	0.00273	0.00322	CcSEcCtD
Benzonatate—Hypersensitivity—Tamoxifen—breast cancer	0.00268	0.00317	CcSEcCtD
Benzonatate—Constipation—Vinorelbine—breast cancer	0.00267	0.00315	CcSEcCtD
Benzonatate—Hypersensitivity—Melphalan—breast cancer	0.00263	0.0031	CcSEcCtD
Benzonatate—Convulsion—Fluorouracil—breast cancer	0.00261	0.00308	CcSEcCtD
Benzonatate—Confusional state—Mitoxantrone—breast cancer	0.00259	0.00306	CcSEcCtD
Benzonatate—Confusional state—Irinotecan—breast cancer	0.00259	0.00306	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—CXCR4—breast cancer	0.00259	0.0208	CbGpPWpGaD
Benzonatate—Pruritus—Tamoxifen—breast cancer	0.00258	0.00304	CcSEcCtD
Benzonatate—Feeling abnormal—Vinorelbine—breast cancer	0.00257	0.00303	CcSEcCtD
Benzonatate—Hypersensitivity—Goserelin—breast cancer	0.00256	0.00303	CcSEcCtD
Benzonatate—Constipation—Thiotepa—breast cancer	0.00255	0.003	CcSEcCtD
Benzonatate—Shock—Irinotecan—breast cancer	0.00253	0.00298	CcSEcCtD
Benzonatate—Shock—Mitoxantrone—breast cancer	0.00253	0.00298	CcSEcCtD
Benzonatate—Pruritus—Melphalan—breast cancer	0.00252	0.00298	CcSEcCtD
Benzonatate—Hypoaesthesia—Docetaxel—breast cancer	0.00249	0.00294	CcSEcCtD
Benzonatate—Confusional state—Fluorouracil—breast cancer	0.00248	0.00293	CcSEcCtD
Benzonatate—Dizziness—Vinblastine—breast cancer	0.00248	0.00293	CcSEcCtD
Benzonatate—Pruritus—Goserelin—breast cancer	0.00246	0.00291	CcSEcCtD
Benzonatate—Feeling abnormal—Thiotepa—breast cancer	0.00245	0.00289	CcSEcCtD
Benzonatate—Nausea—Chlorambucil—breast cancer	0.00243	0.00287	CcSEcCtD
Benzonatate—Hypoaesthesia—Capecitabine—breast cancer	0.00241	0.00284	CcSEcCtD
Benzonatate—Dizziness—Tamoxifen—breast cancer	0.00241	0.00284	CcSEcCtD
Benzonatate—Tremor—Paclitaxel—breast cancer	0.00241	0.00284	CcSEcCtD
Benzonatate—Agitation—Paclitaxel—breast cancer	0.00236	0.00279	CcSEcCtD
Benzonatate—Headache—Vinblastine—breast cancer	0.00235	0.00277	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—YBX1—breast cancer	0.00232	0.0186	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—HADHB—breast cancer	0.00232	0.0186	CbGpPWpGaD
Benzonatate—Dizziness—Goserelin—breast cancer	0.0023	0.00272	CcSEcCtD
Benzonatate—Rash—Tamoxifen—breast cancer	0.0023	0.00271	CcSEcCtD
Benzonatate—Hypersensitivity—Vinorelbine—breast cancer	0.0023	0.00271	CcSEcCtD
Benzonatate—Headache—Tamoxifen—breast cancer	0.00228	0.00269	CcSEcCtD
Benzonatate—Rash—Melphalan—breast cancer	0.00225	0.00265	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—ARTN—breast cancer	0.00225	0.018	CbGpPWpGaD
Benzonatate—Nausea—Vinblastine—breast cancer	0.00223	0.00263	CcSEcCtD
Benzonatate—Convulsion—Paclitaxel—breast cancer	0.00223	0.00263	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—THRB—breast cancer	0.00221	0.0177	CbGpPWpGaD
Benzonatate—Pruritus—Vinorelbine—breast cancer	0.00221	0.0026	CcSEcCtD
Benzonatate—Constipation—Mitoxantrone—breast cancer	0.0022	0.00259	CcSEcCtD
Benzonatate—Constipation—Irinotecan—breast cancer	0.0022	0.00259	CcSEcCtD
Benzonatate—Rash—Goserelin—breast cancer	0.00219	0.00259	CcSEcCtD
Benzonatate—Hypersensitivity—Thiotepa—breast cancer	0.00219	0.00259	CcSEcCtD
Benzonatate—Headache—Goserelin—breast cancer	0.00218	0.00257	CcSEcCtD
Benzonatate—Nausea—Tamoxifen—breast cancer	0.00216	0.00255	CcSEcCtD
Benzonatate—Abdominal discomfort—Methotrexate—breast cancer	0.00216	0.00255	CcSEcCtD
Benzonatate—Constipation—Gemcitabine—breast cancer	0.00214	0.00253	CcSEcCtD
Benzonatate—Nausea—Melphalan—breast cancer	0.00212	0.0025	CcSEcCtD
Benzonatate—Feeling abnormal—Irinotecan—breast cancer	0.00212	0.0025	CcSEcCtD
Benzonatate—Feeling abnormal—Mitoxantrone—breast cancer	0.00212	0.0025	CcSEcCtD
Benzonatate—Confusional state—Paclitaxel—breast cancer	0.00211	0.00249	CcSEcCtD
Benzonatate—Pruritus—Thiotepa—breast cancer	0.00211	0.00249	CcSEcCtD
Benzonatate—Nausea—Goserelin—breast cancer	0.00207	0.00244	CcSEcCtD
Benzonatate—Feeling abnormal—Gemcitabine—breast cancer	0.00206	0.00244	CcSEcCtD
Benzonatate—Shock—Paclitaxel—breast cancer	0.00206	0.00243	CcSEcCtD
Benzonatate—Dizziness—Vinorelbine—breast cancer	0.00206	0.00243	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—NTN4—breast cancer	0.00206	0.0165	CbGpPWpGaD
Benzonatate—Feeling abnormal—Fluorouracil—breast cancer	0.00203	0.00239	CcSEcCtD
Benzonatate—Tremor—Capecitabine—breast cancer	0.00197	0.00233	CcSEcCtD
Benzonatate—Dizziness—Thiotepa—breast cancer	0.00197	0.00232	CcSEcCtD
Benzonatate—Rash—Vinorelbine—breast cancer	0.00197	0.00232	CcSEcCtD
Benzonatate—Headache—Vinorelbine—breast cancer	0.00195	0.0023	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—NRG1—breast cancer	0.00193	0.0154	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—RANBP9—breast cancer	0.00191	0.0153	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—PPARGC1B—breast cancer	0.00191	0.0153	CbGpPWpGaD
Benzonatate—Hypersensitivity—Mitoxantrone—breast cancer	0.00189	0.00224	CcSEcCtD
Benzonatate—Hypersensitivity—Irinotecan—breast cancer	0.00189	0.00224	CcSEcCtD
Benzonatate—Convulsion—Docetaxel—breast cancer	0.00189	0.00223	CcSEcCtD
Benzonatate—Rash—Thiotepa—breast cancer	0.00188	0.00221	CcSEcCtD
Benzonatate—Headache—Thiotepa—breast cancer	0.00186	0.0022	CcSEcCtD
Benzonatate—Nausea—Vinorelbine—breast cancer	0.00185	0.00218	CcSEcCtD
Benzonatate—Hypersensitivity—Fluorouracil—breast cancer	0.00181	0.00214	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—EVL—breast cancer	0.0018	0.0144	CbGpPWpGaD
Benzonatate—Constipation—Paclitaxel—breast cancer	0.00179	0.00212	CcSEcCtD
Benzonatate—Confusional state—Docetaxel—breast cancer	0.00179	0.00211	CcSEcCtD
Benzonatate—Pruritus—Gemcitabine—breast cancer	0.00177	0.00209	CcSEcCtD
Benzonatate—Nausea—Thiotepa—breast cancer	0.00177	0.00209	CcSEcCtD
Benzonatate—Shock—Docetaxel—breast cancer	0.00175	0.00206	CcSEcCtD
Benzonatate—Pruritus—Fluorouracil—breast cancer	0.00174	0.00206	CcSEcCtD
Benzonatate—Confusional state—Capecitabine—breast cancer	0.00173	0.00205	CcSEcCtD
Benzonatate—Feeling abnormal—Paclitaxel—breast cancer	0.00173	0.00204	CcSEcCtD
Benzonatate—Dizziness—Irinotecan—breast cancer	0.0017	0.00201	CcSEcCtD
Benzonatate—Shock—Capecitabine—breast cancer	0.00169	0.002	CcSEcCtD
Benzonatate—Hypoaesthesia—Epirubicin—breast cancer	0.00168	0.00198	CcSEcCtD
Benzonatate—Dizziness—Fluorouracil—breast cancer	0.00163	0.00192	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—EPHB4—breast cancer	0.00163	0.013	CbGpPWpGaD
Benzonatate—Rash—Mitoxantrone—breast cancer	0.00162	0.00191	CcSEcCtD
Benzonatate—Rash—Irinotecan—breast cancer	0.00162	0.00191	CcSEcCtD
Benzonatate—Headache—Mitoxantrone—breast cancer	0.00161	0.0019	CcSEcCtD
Benzonatate—Headache—Irinotecan—breast cancer	0.00161	0.0019	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.00161	0.0129	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ARTN—breast cancer	0.0016	0.0129	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—KDR—breast cancer	0.00158	0.0127	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—PAK1—breast cancer	0.00158	0.0127	CbGpPWpGaD
Benzonatate—Rash—Gemcitabine—breast cancer	0.00158	0.00186	CcSEcCtD
Benzonatate—Headache—Gemcitabine—breast cancer	0.00157	0.00185	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—EFNA1—breast cancer	0.00156	0.0125	CbGpPWpGaD
Benzonatate—Hypoaesthesia—Doxorubicin—breast cancer	0.00155	0.00183	CcSEcCtD
Benzonatate—Rash—Fluorouracil—breast cancer	0.00155	0.00183	CcSEcCtD
Benzonatate—Hypersensitivity—Paclitaxel—breast cancer	0.00154	0.00182	CcSEcCtD
Benzonatate—Headache—Fluorouracil—breast cancer	0.00154	0.00182	CcSEcCtD
Benzonatate—Nausea—Irinotecan—breast cancer	0.00153	0.0018	CcSEcCtD
Benzonatate—Nausea—Mitoxantrone—breast cancer	0.00153	0.0018	CcSEcCtD
Benzonatate—Constipation—Docetaxel—breast cancer	0.00152	0.00179	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—breast cancer	0.00149	0.0119	CbGpPWpGaD
Benzonatate—Nausea—Gemcitabine—breast cancer	0.00149	0.00176	CcSEcCtD
Benzonatate—Pruritus—Paclitaxel—breast cancer	0.00148	0.00175	CcSEcCtD
Benzonatate—Constipation—Capecitabine—breast cancer	0.00147	0.00174	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—NTN4—breast cancer	0.00147	0.0118	CbGpPWpGaD
Benzonatate—Feeling abnormal—Docetaxel—breast cancer	0.00146	0.00173	CcSEcCtD
Benzonatate—Nausea—Fluorouracil—breast cancer	0.00146	0.00173	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—KIT—breast cancer	0.00146	0.0117	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—NRCAM—breast cancer	0.00145	0.0116	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.00145	0.0116	CbGpPWpGaD
Benzonatate—Feeling abnormal—Capecitabine—breast cancer	0.00142	0.00167	CcSEcCtD
Benzonatate—Dizziness—Paclitaxel—breast cancer	0.00139	0.00164	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.00137	0.011	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—RANBP9—breast cancer	0.00136	0.0109	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—EBF1—breast cancer	0.00136	0.0109	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HNF4G—breast cancer	0.00136	0.0109	CbGpPWpGaD
Benzonatate—Convulsion—Methotrexate—breast cancer	0.00136	0.0016	CcSEcCtD
Benzonatate—Agitation—Epirubicin—breast cancer	0.00135	0.00159	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—IGF1—breast cancer	0.00133	0.0107	CbGpPWpGaD
Benzonatate—Rash—Paclitaxel—breast cancer	0.00132	0.00156	CcSEcCtD
Benzonatate—Headache—Paclitaxel—breast cancer	0.00131	0.00155	CcSEcCtD
Benzonatate—Hypersensitivity—Docetaxel—breast cancer	0.00131	0.00155	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—SCN10A—breast cancer	0.00129	0.0104	CbGpPWpGaD
Benzonatate—Confusional state—Methotrexate—breast cancer	0.00129	0.00152	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—EVL—breast cancer	0.00128	0.0103	CbGpPWpGaD
Benzonatate—Convulsion—Epirubicin—breast cancer	0.00127	0.0015	CcSEcCtD
Benzonatate—Hypersensitivity—Capecitabine—breast cancer	0.00127	0.0015	CcSEcCtD
Benzonatate—Pruritus—Docetaxel—breast cancer	0.00126	0.00148	CcSEcCtD
Benzonatate—Agitation—Doxorubicin—breast cancer	0.00125	0.00147	CcSEcCtD
Benzonatate—Nausea—Paclitaxel—breast cancer	0.00125	0.00147	CcSEcCtD
Benzonatate—Pruritus—Capecitabine—breast cancer	0.00122	0.00144	CcSEcCtD
Benzonatate—Confusional state—Epirubicin—breast cancer	0.00121	0.00143	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—GATA3—breast cancer	0.00119	0.00957	CbGpPWpGaD
Benzonatate—Shock—Epirubicin—breast cancer	0.00118	0.00139	CcSEcCtD
Benzonatate—Convulsion—Doxorubicin—breast cancer	0.00118	0.00139	CcSEcCtD
Benzonatate—Dizziness—Docetaxel—breast cancer	0.00118	0.00139	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—EPHB4—breast cancer	0.00116	0.0093	CbGpPWpGaD
Benzonatate—Dizziness—Capecitabine—breast cancer	0.00114	0.00134	CcSEcCtD
Benzonatate—Rash—Docetaxel—breast cancer	0.00112	0.00132	CcSEcCtD
Benzonatate—Confusional state—Doxorubicin—breast cancer	0.00112	0.00132	CcSEcCtD
Benzonatate—Headache—Docetaxel—breast cancer	0.00111	0.00131	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—EFNA1—breast cancer	0.00111	0.00892	CbGpPWpGaD
Benzonatate—Shock—Doxorubicin—breast cancer	0.00109	0.00129	CcSEcCtD
Benzonatate—Rash—Capecitabine—breast cancer	0.00108	0.00128	CcSEcCtD
Benzonatate—Headache—Capecitabine—breast cancer	0.00108	0.00127	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—ESR2—breast cancer	0.00107	0.00859	CbGpPWpGaD
Benzonatate—Nausea—Docetaxel—breast cancer	0.00106	0.00125	CcSEcCtD
Benzonatate—Feeling abnormal—Methotrexate—breast cancer	0.00106	0.00125	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—FGFR1—breast cancer	0.00104	0.00837	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NRCAM—breast cancer	0.00103	0.00829	CbGpPWpGaD
Benzonatate—Constipation—Epirubicin—breast cancer	0.00102	0.00121	CcSEcCtD
Benzonatate—Nausea—Capecitabine—breast cancer	0.00102	0.00121	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—EGR1—breast cancer	0.001	0.00804	CbGpPWpGaD
Benzonatate—Feeling abnormal—Epirubicin—breast cancer	0.000988	0.00117	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—ANGPTL4—breast cancer	0.000972	0.00779	CbGpPWpGaD
Benzonatate—Constipation—Doxorubicin—breast cancer	0.000948	0.00112	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—AR—breast cancer	0.000947	0.00759	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—WNT10B—breast cancer	0.000946	0.00758	CbGpPWpGaD
Benzonatate—Hypersensitivity—Methotrexate—breast cancer	0.000944	0.00111	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—SCN10A—breast cancer	0.000922	0.00739	CbGpPWpGaD
Benzonatate—Feeling abnormal—Doxorubicin—breast cancer	0.000914	0.00108	CcSEcCtD
Benzonatate—Pruritus—Methotrexate—breast cancer	0.000906	0.00107	CcSEcCtD
Benzonatate—Hypersensitivity—Epirubicin—breast cancer	0.000883	0.00104	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—CFL1—breast cancer	0.000862	0.00691	CbGpPWpGaD
Benzonatate—Pruritus—Epirubicin—breast cancer	0.000848	0.001	CcSEcCtD
Benzonatate—Dizziness—Methotrexate—breast cancer	0.000847	0.001	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—HES1—breast cancer	0.000832	0.00667	CbGpPWpGaD
Benzonatate—Hypersensitivity—Doxorubicin—breast cancer	0.000817	0.000964	CcSEcCtD
Benzonatate—Rash—Methotrexate—breast cancer	0.000807	0.000953	CcSEcCtD
Benzonatate—Headache—Methotrexate—breast cancer	0.000802	0.000947	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—TGFB1—breast cancer	0.0008	0.00641	CbGpPWpGaD
Benzonatate—Dizziness—Epirubicin—breast cancer	0.000793	0.000935	CcSEcCtD
Benzonatate—Pruritus—Doxorubicin—breast cancer	0.000785	0.000926	CcSEcCtD
Benzonatate—Nausea—Methotrexate—breast cancer	0.000761	0.000898	CcSEcCtD
Benzonatate—Rash—Epirubicin—breast cancer	0.000756	0.000892	CcSEcCtD
Benzonatate—Headache—Epirubicin—breast cancer	0.000751	0.000886	CcSEcCtD
Benzonatate—Dizziness—Doxorubicin—breast cancer	0.000733	0.000865	CcSEcCtD
Benzonatate—Nausea—Epirubicin—breast cancer	0.000712	0.00084	CcSEcCtD
Benzonatate—Rash—Doxorubicin—breast cancer	0.000699	0.000825	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000697	0.00559	CbGpPWpGaD
Benzonatate—Headache—Doxorubicin—breast cancer	0.000695	0.00082	CcSEcCtD
Benzonatate—Nausea—Doxorubicin—breast cancer	0.000659	0.000777	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—CFL1—breast cancer	0.000615	0.00493	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—PAK1—breast cancer	0.000597	0.00479	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MED12—breast cancer	0.000584	0.00468	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—HSP90AA1—breast cancer	0.000566	0.00454	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NCOA3—breast cancer	0.000558	0.00448	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—WNT1—breast cancer	0.000558	0.00448	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—SRC—breast cancer	0.000556	0.00446	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—SLC2A2—breast cancer	0.000554	0.00445	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—ADAM10—breast cancer	0.000542	0.00435	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—MAPK3—breast cancer	0.000513	0.00411	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—ABL1—breast cancer	0.00049	0.00393	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—EGFR—breast cancer	0.000488	0.00391	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NCOA2—breast cancer	0.000466	0.00374	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CXCL8—breast cancer	0.000452	0.00363	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL1B—breast cancer	0.000434	0.00348	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CASP3—breast cancer	0.000433	0.00347	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PAK1—breast cancer	0.000426	0.00342	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—JUN—breast cancer	0.000421	0.00337	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—breast cancer	0.000417	0.00335	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HSP90AA1—breast cancer	0.000404	0.00324	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—FGFR1—breast cancer	0.000395	0.00316	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NCOA1—breast cancer	0.000393	0.00315	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ADAM10—breast cancer	0.000387	0.0031	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—FGF10—breast cancer	0.000376	0.00302	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—KDR—breast cancer	0.000372	0.00298	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—VEGFA—breast cancer	0.000367	0.00295	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MET—breast cancer	0.000364	0.00292	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ABL1—breast cancer	0.00035	0.00281	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—SMAD4—breast cancer	0.000339	0.00272	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HES1—breast cancer	0.000331	0.00265	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NCOR1—breast cancer	0.000329	0.00264	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—TNF—breast cancer	0.000315	0.00253	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MMP2—breast cancer	0.000303	0.00243	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—FGFR1—breast cancer	0.000282	0.00226	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—LEP—breast cancer	0.000271	0.00217	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—RAF1—breast cancer	0.000269	0.00215	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—ERBB2—breast cancer	0.000266	0.00213	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—KDR—breast cancer	0.000265	0.00213	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MET—breast cancer	0.00026	0.00208	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CDK4—breast cancer	0.00026	0.00208	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL6—breast cancer	0.000254	0.00204	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NOTCH1—breast cancer	0.00025	0.002	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MMP9—breast cancer	0.000228	0.00183	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—AKT2—breast cancer	0.000224	0.00179	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MMP2—breast cancer	0.000217	0.00174	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—SRC—breast cancer	0.00021	0.00169	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—VEGFA—breast cancer	0.000205	0.00164	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MAPK3—breast cancer	0.000194	0.00155	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—RAF1—breast cancer	0.000192	0.00154	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—RELA—breast cancer	0.000191	0.00153	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ERBB2—breast cancer	0.00019	0.00152	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—EGFR—breast cancer	0.000184	0.00148	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—KRAS—breast cancer	0.000174	0.0014	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CTNNB1—breast cancer	0.000166	0.00133	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MMP9—breast cancer	0.000163	0.0013	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—SRC—breast cancer	0.00015	0.0012	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—HRAS—breast cancer	0.000148	0.00119	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—VEGFA—breast cancer	0.000146	0.00117	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—STAT3—breast cancer	0.000145	0.00116	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—IL6—breast cancer	0.000142	0.00114	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MAPK3—breast cancer	0.000138	0.00111	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TGFB1—breast cancer	0.000134	0.00108	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—EGFR—breast cancer	0.000131	0.00105	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TNF—breast cancer	0.000125	0.001	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—KRAS—breast cancer	0.000124	0.000996	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HRAS—breast cancer	0.000106	0.000847	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—IL6—breast cancer	0.000101	0.00081	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—AKT1—breast cancer	9.32e-05	0.000748	CbGpPWpGaD
